Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles
Executive Summary
All too often, pharmaceutical companies and investors put up hurdles, but they can and must identify indications and assets with high future market access potential in early stages by adjusting the early screening and evaluation process.